Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jagust, W. J.
Right arrow Articles by Ober, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jagust, W. J.
Right arrow Articles by Ober, B.
NEUROLOGY 1988;38:909
© 1988 American Academy of Neurology

Longitudinal studies of regional cerebral metabolism in Alzheimer's disease

W. J. Jagust, MD, R. P. Friedland, MD, T. F. Budinger, MD, PhD, E. Koss, PhD and B. Ober, PhD

From the Department of Neurology (Drs. Jagust, Friedland, and Koss), School of Medicine, University of California, Davis; Veterans Administration Medical Center (Drs. Jagust, Friedland, Koss, and Ober), Martinez, CA; Donner Laboratory (Drs. Jagust, Friedland, and Budinger), University of California, Berkeley; Veterans Administration Medical Center (Dr. Ober), Livermore, CA; and Laboratory of Neurosciences (Drs. Friedland and Koss), National Institute on Aging, NIH, Betbeada, MD.

Measurement of cerebral glucose metabolism in six patients with Alzheimer's disease using positron emission tomography demonstrated that hypometabolism remained relatively more severe in parietal cortex than in frontal cortex over time. Lateral metabolic asymmetries were preserved in less severely involved brain regions, but were less stable in parietal cortex.

Address correspondence and reprint requests to Dr. Jagust, Department of Neurology (127), Veterans Administration Medical Center, 150 Muir Road, Martinez, CA 94553.

Supported by NIH grant AG05890 from the National Institute on Aging, by the Medical Research Service of the United States Veterans Administration, and by the Director, Office of Energy Research, Office of Health and Environmental Research of the United States Department of Energy under contract DE-AC03-76SF00098.

Presented in part at the thirty-ninth annual meeting of the American Academy of Neurology, New York, NY, April 1987.

Received June 16, 1987. Accepted for publication in final form October 23, 1987.




This article has been cited by other articles:


Home page
Br. J. Radiol.Home page
K HERHOLZ, S F CARTER, and M JONES
Positron emission tomography imaging in dementia
Br. J. Radiol., December 1, 2007; 80(Special_Issue_2): S160 - S167.
[Abstract] [Full Text] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
N. Hirono, M. Hashimoto, K. Ishii, H. Kazui, and E. Mori
One-Year Change in Cerebral Glucose Metabolism in Patients With Alzheimer's Disease
J Neuropsychiatry Clin Neurosci, November 1, 2004; 16(4): 488 - 492.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
T. Yoshikawa, K. Murase, N. Oku, M. Imaizumi, M. Takasawa, P. Rishu, Y. Kimura, Y. Ikejiri, K. Kitagawa, M. Hori, et al.
Heterogeneity of Cerebral Blood Flow in Alzheimer Disease and Vascular Dementia
AJNR Am. J. Neuroradiol., August 1, 2003; 24(7): 1341 - 1347.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. L. Grady, A. R. McIntosh, S. Beig, M. L. Keightley, H. Burian, and S. E. Black
Evidence from Functional Neuroimaging of a Compensatory Prefrontal Network in Alzheimer's Disease
J. Neurosci., February 1, 2003; 23(3): 986 - 993.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
G. E. Alexander, K. Chen, P. Pietrini, S. I. Rapoport, and E. M. Reiman
Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies
Am J Psychiatry, May 1, 2002; 159(5): 738 - 745.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
C. L. Grady, M. L. Furey, P. Pietrini, B. Horwitz, and S. I. Rapoport
Altered brain functional connectivity and impaired short-term memory in Alzheimer's disease
Brain, April 1, 2001; 124(4): 739 - 756.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
B TOONE
Cerebral dysfunction and psychotic symptoms in Alzheimer's disease
J. Neurol. Neurosurg. Psychiatry, August 1, 2000; 69(2): 148 - 149.
[Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
M. J. de Leon, T. McRae, H. Rusinek, A. Convit, S. De Santi, C. Tarshish, J. Golomb, N. Volkow, K. Daisley, N. Orentreich, et al.
Cortisol Reduces Hippocampal Glucose Metabolism in Normal Elderly, but Not in Alzheimer's Disease
J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3251 - 3259.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by AAN Enterprises, Inc.